ED
PX

Exane Derivatives’s Praxair Inc PX Stock Holding History

Exane Derivatives’s Portfolio PX Stock Details PX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$161 – 764
2018
Q3 		$161 Sell
1
-25
-96% -$4.01K ﹤0.01% 601
2018
Q2 		$4.13K Sell
26
-176
-87% -$27.2K ﹤0.01% 477
2018
Q1 		$28.9K Buy
202
+133
+193% +$20.7K 0.01% 379
2017
Q4 		$10.7K Sell
69
-423
-86% -$62.8K ﹤0.01% 399
2017
Q3 		$68.7K Sell
492
-334
-40% -$44.5K 0.01% 286
2017
Q2 		$109K Buy
+826
New +$106K 0.02% 265

Other funds holding PX

SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
CAM
Covenant Asset Management Chester, New Jersey $595M AUM 38.14% 1-Year Est. Return
AWM
Alterna Wealth Management Houston, Texas $174M AUM 15.45% 1-Year Est. Return
GFP
Gryphon Financial Partners Columbus, Ohio $1.13B AUM 30.28% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Exane Derivatives's PX Position: Q4 2018 in Review

Exane Derivatives sold out of Praxair Inc (PX) in Q4 2018, closing a stake of 1 share — an estimated $161 sold.

Exane Derivatives first reported a position in PX in Q2 2017 and held it in 6 quarters. The position peaked at $109K in Q2 2017. 6 funds tracked by Wall St. Rank hold PX as of Q4 2018.

  • Exane Derivatives reported no remaining Praxair Inc position as of Q4 2018 after selling out during the quarter.
  • Exane Derivatives sold 1 Praxair Inc share in Q4 2018, an estimated $161.
  • Exane Derivatives first reported a position in Praxair Inc in Q2 2017 and held it in 6 quarters.
  • Exane Derivatives's Praxair Inc position peaked at $109K in Q2 2017.
  • 6 funds tracked by Wall St. Rank held Praxair Inc as of Q4 2018.

Based on Exane Derivatives's 13F filing for Q4 2018, filed 31 Jan 2019.